Selzentry

maraviroc (MVC)

Not recommended as component of an initial regimen
Entry Inhibitor

Standard Dose

The recommended dose varies depending on other medications being taken but will be either 150, 300, or 600 mg twice daily (available in 150 mg and 300 mg tablets). Approved for adults and children at least two years old weighing at least 22 pounds (10 kg) and having a creatinine clearance of at least 30mL/min (measurement of kidney function); dose depends on weight. Available in a 20 mg/mL oral solution as well as 25 mg and 75 mg tablets. The oral solution should be administered using the included press-in bottle adapter and oral dosing syringe. Can be taken without regard to food. Must be taken in combination with another antiretroviral(s).

Take missed dose as soon as possible, unless it is closer in time to your next dose. Do not double up on your next dose. Before you start Selzentry, you will need a specific blood test called a Trofile to determine if this medication will work for you.


Manufacturer

ViiV Healthcare
viivhealthcare.com
selzentry.com
(877) 844-8872

AWP

300 mg tablets, 60 tablets: $1,874.44/month

Potential Side Effects and Toxicity

Potential Drug Interactions

More Information

Doctor Comments

Activist Comments